Latest News in the pharma Industry

Top Stories

Amgen & Micromet Enter into Merger Agreement

Amgen & Micromet Enter into Merger Agreement

29 Jan 2012

The acquisition gives Amgen access to a novel cancer treatment.

Read more 
Watson Pharmaceuticals Acquires Ascent Pharmahealth

Watson Pharmaceuticals Acquires Ascent Pharmahealth

29 Jan 2012

The acquisition makes Watson the fifth-largest generic pharmaceutical company in Australia in terms of revenue, and the second largest in terms of total molecules possessed.

Read more 
Celgene and Avila Therapeutics Announce Acquisition Deal

Celgene and Avila Therapeutics Announce Acquisition Deal

29 Jan 2012

Celgene will acquire Avila Therapeutics for $350 million in cash.

Read more 
Pii Starts Facility Expansion for Aseptic Manufacturing

Pii Starts Facility Expansion for Aseptic Manufacturing

20 Jan 2012

Pharmaceutics International, Inc. has begun construction of a new cGMP aseptic fill/finish manufacturing facility.

Read more 
Jazz Closes Acquisition of Azur Pharma

Jazz Closes Acquisition of Azur Pharma

20 Jan 2012

Jazz Pharmaceuticals has bought Irish firm Azur Pharma in a deal that creates a specialty drug company headquartered in Dublin.

Read more 
AMRI's UK Facility Gains MHRA Certificate

AMRI's UK Facility Gains MHRA Certificate

19 Jan 2012

The MHRA certificate covers general GMP manufacturing operations, and laboratory controls designed for the production and release of APIs and intermediates.

Read more 
Takeda Starts Restructuring after Nycomed Acquisition

Takeda Starts Restructuring after Nycomed Acquisition

19 Jan 2012

The Japanese company will consolidate its R&D sites and functions, cutting its global workforce by approximately 2,800 by the end of fiscal 2015.

Read more 
Novartis Receives Chinese Approval for Lucentis

Novartis Receives Chinese Approval for Lucentis

19 Jan 2012

Novartis received Chinese regulatory approval for its eye drug Lucentis, and it is launching the diabetes treatment Galvus in China.

Read more 
Medivation & Pfizer to Discontinue Dimebon Development

Medivation & Pfizer to Discontinue Dimebon Development

18 Jan 2012

Medivation and Pfizer will discontinue development of dimebon for all indications and will terminate the ongoing open label extension study in Alzheimer's disease.

Read more 
Evotec & Harvard Expand Alliance

Evotec & Harvard Expand Alliance

18 Jan 2012

The alliance will pursue systematic and unbiased approaches towards the identification of kidney disease relevant mechanisms, with particular interest in mechanisms with disease-modifying potential.

Read more 
Scil Proteins Inks Supply Pact with Actavis

Scil Proteins Inks Supply Pact with Actavis

18 Jan 2012

Scil Proteins has signed a supply agreement with Actavis for the manufacturing of Reteplase.

Read more 
Carbogen Amcis Acquires Creapharm Parenterals

Carbogen Amcis Acquires Creapharm Parenterals

17 Jan 2012

The acquisition will extend Carbogen Amcis’ range of development and manufacturing services by adding formulation, lyophilization services and sterile GMP capabilities for the fast supply of drug products.

Read more